Home Cart Sign in  
Chemical Structure| 176199-48-7 Chemical Structure| 176199-48-7

Structure of Eglumegad
CAS No.: 176199-48-7

Chemical Structure| 176199-48-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LY354740 is a highly potent, efficacious and selective group II (mGlu2/3) receptor agonist, produces > 90% suppression of forskolin-stimulated cAMP formation with an EC50 of 5.1 ± 0.3 nM.

Synonyms: LY354740; Eglumetad

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Eglumegad

CAS No. :176199-48-7
Formula : C8H11NO4
M.W : 185.18
SMILES Code : OC([C@]1([C@]2([H])[C@@H](C(O)=O)[C@]2([H])CC1)N)=O
Synonyms :
LY354740; Eglumetad
MDL No. :MFCD04113018
InChI Key :VTAARTQTOOYTES-RGDLXGNYSA-N
Pubchem ID :213056

Safety of Eglumegad

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Eglumegad

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male C57BL/6 wild-type mice Acute or sub-acute MPTP-induced Parkinson’s disease mice models Intraperitoneal injection 0.1, 1, 10 mg/kg, i.p. Once daily for 7 days LY354740 reduced extracellular glutamate concentration, inhibited phosphorylation of Fyn/NMDARs, and expression of PLK2/pS129 α-synuclein. LY341495 amplified the lesions in sub-acute MPTP mice models. Front Pharmacol. 2020 Feb 28;11:183
Mice Hindpaw ischemia model Spinal application 10 nM Single administration LY354740 blocked the reduction in mechanical thresholds for paw-withdrawal reflex after hindpaw ischemia Sci Rep. 2015 Jul 13;5:11191
Rats and mice Spatial memory consolidation model Intraperitoneal injection 6 mg/kg for rats, 10 mg/kg for mice Single injection, tested after 6 hours To evaluate the effect of eglumetad on spatial memory consolidation, results showed that eglumetad injections impaired early consolidation of spatial memory Sci Rep. 2024 Mar 12;14(1):5977
Rats and dogs Panic-vulnerable rat model Oral 30 to 1000 mg/kg To evaluate the anxiolytic activity of Eglumegad in anxiety and panic models Depress Anxiety. 2020 Aug;37(8):747-759

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.40mL

1.08mL

0.54mL

27.00mL

5.40mL

2.70mL

54.00mL

10.80mL

5.40mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories